Literature DB >> 11145293

Novel germline APC mutations in Swedish patients with familial adenomatous polyposis and Gardner syndrome.

M Nilbert1, J Fernebro, U Kristoffersson.   

Abstract

BACKGROUND: Familial adenomatous polyposis (FAP) is a familial cancer syndrome in which affected individuals develop multiple adenomatous polyps and are thereby at greatly increased risk of developing colorectal cancer. Gardner syndrome is a variant of FAP, in which the patients also develop extraintestinal tumors, in particular osteomas and desmoid tumors. An attenuated form of the disease (AFAP) is associated with fewer polyps, but still a high risk for colorectal cancer. Germline mutations in the adenomatosis polyposis coli (APC) gene cause FAP and Gardner syndrome and have recently been associated also with the development of AFAP.
METHODS: We have analysed the entire APC gene for germline mutations in 7 patients with FAP and in 6 patients with suspected AFAP. Mutation screening was performed by direct sequencing of exons 1-14 and using the protein truncation test for analysis of exon 15.
RESULTS: Novel disease-causing germline mutations, all of which resulted in truncation of the APC protein, were identified in 6 of the 7 patients with FAP or Gardner syndrome. No APC mutation was detected in any of the 6 patients with suspected AFAP.
CONCLUSIONS: This study reports novel FAP- and Gardner syndrome-causing mutations in the APC gene. The lack of APC mutations in patients with multiple polyps at young age indicates that other genetic defects may cause this phenotype.

Entities:  

Mesh:

Year:  2000        PMID: 11145293     DOI: 10.1080/003655200750056691

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

Review 1.  Desmoid tumour in familial adenomatous polyposis. A review of literature.

Authors:  A L Knudsen; S Bülow
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

2.  Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis.

Authors:  A Rohlin; Y Engwall; K Fritzell; K Göransson; A Bergsten; Z Einbeigi; M Nilbert; P Karlsson; J Björk; M Nordling
Journal:  Oncogene       Date:  2011-06-06       Impact factor: 9.867

3.  APC Splicing Mutations Leading to In-Frame Exon 12 or Exon 13 Skipping Are Rare Events in FAP Pathogenesis and Define the Clinical Outcome.

Authors:  Vittoria Disciglio; Giovanna Forte; Candida Fasano; Paola Sanese; Martina Lepore Signorile; Katia De Marco; Valentina Grossi; Filomena Cariola; Cristiano Simone
Journal:  Genes (Basel)       Date:  2021-02-28       Impact factor: 4.096

4.  Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72.

Authors:  Mef Nilbert; Ulf Kristoffersson; Mats Ericsson; Oskar Johannsson; Eva Rambech; Peter Mangell
Journal:  BMC Med Genet       Date:  2008-11-26       Impact factor: 2.103

5.  Clinical characterization and the mutation spectrum in Swedish adenomatous polyposis families.

Authors:  Gunilla Kanter-Smoler; Kaisa Fritzell; Anna Rohlin; Yvonne Engwall; Birgitta Hallberg; Annika Bergman; Johan Meuller; Henrik Grönberg; Per Karlsson; Jan Björk; Margareta Nordling
Journal:  BMC Med       Date:  2008-04-24       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.